Many cardiologists monitor pacemakers and other cardiovascular implantable electronic devices (CIEDs) remotely. Forward-thinking practices are now integrating their monitoring software into their electronic medical records system (EMR)
Strain echocardiography allows detection of small changes in ventricular function, enabling early cardioprotection for cancer patients whose chemotherapy puts them at risk for heart failure.
The ABSORB trial is assessing a new bioabsorbable device designed to match the performance of metallic drug-eluting stents before it dissolves to avoid long-term thrombotic risk.
Submicroscopic nanoparticles may help overcome the obstacles that hamper traditional anti-cancer drugs. Their size and other unique properties enable targeted drug delivery to hard-to-access tumors, as well as aiding tumor boundary visualization.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Providing world-class cancer care can be demanding. With more than 46,000 inpatients treated at Cleveland Clinic’s Taussig Cancer Institute in 2010 alone, Cancer Institute nurses understand this all too well.
Mental health is increasingly recognized as important to heart health. Here are lessons from Cleveland Clinic’s introduction of mental health services into a cardiology clinic.
Cleveland Clinic’s move toward value-based purchasing saved more than $150 million over two years, with a third of the savings in cardiovascular care. Cardiovascular leaders share insights gained.
International effort allows experts to confer on complex cases
Apolipoprotein A1, a major component of HDL, blocks metastatic malignant melanoma and lung cancer through multiple pathways. ApoA1 injections not only inhibit tumor growth and progression in mice, but spur tumor and metastases regression.
Recycling isn’t just good for the earth—it can benefit a hospital’s bottom line, too.